Nomifensine in Parkinson's disease.

Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain

1971 • 405 citations

Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

1974 • 289 citations

Nomifensine: A potent dopaminergic agonist of antiparkinson potential

1975 • 107 citations

Effect of nomifensine (Hoe 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes

1974 • 106 citations

Methlphenidate-like effects of the new antidepressant drug nomifensine (HOE 984)

1976 • 105 citations

Psychiatric symptoms during<scp>L</scp>-dopa therapy for Parkinson's disease and their relationship to physical disability

1976 • 88 citations

Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3?, 5?-adenosine monophosphate concentrations of rat striatum

1974 • 75 citations

Amphetamines in the treatment of Parkinson's disease.

1975 • 67 citations

8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant.

1973 • 50 citations

A study of the role of catecholamines in the response to various central stimulants

1973 • 46 citations

Histologische Untersuchungen an lymphatischen Organen des Huhnes (Gallus domesticus) w�hrend des ersten Lebensjahres

1973 • 29 citations

Nomifensine in parkinsonism.

1976 • 26 citations

Nomifensine in parkinsonism.

1977 • 20 citations

The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic nerve terminals

1976 • 9 citations